다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Pediatric blood & cancer, v.68 no.8, 2021년, pp.e29109 -
Malterre, Aline (Institut Curie, SIREDO Oncology Center Care, PSL Research University, Paris, France) , Cohen‐Gogo, Sarah (Division of Hematology‐) , Kriegel, Irène (Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada) , d'Avout Fourdinier, Perrine (Department of Anesthesiology, Institut Curie, Paris, France) , Bouleuc, Carole (Department of diagnostic imaging, Institut Curie, Paris, France) , Lemelle, Lauriane (Inter‐) , Surun, Aurore (Disciplinary Supportive Care Department for the Oncology Patient, Institut Curie, Paris, France) , Cordero, Camille (Institut Curie, SIREDO Oncology Center Care, PSL Research University, Paris, France) , Pacquement, Hélène (Institut Curie, SIREDO Oncology Center Care, PSL Research University, Paris, France) , Orbach, Daniel (Institut Curie, SIREDO Oncology Center Care, PSL Research University, Paris, France fr)
AI-Helper
AbstractThe contribution of subcutaneous implantable pleural port catheter (SIPP) for malignant pleural effusions (MPE) management in young patients with cancer, in a palliative care setting is not well explored. This monocentric series analyzed 38 patients, median age 18 years (range 3–25) wi...
Adams J , Auger J , Schiff D . Outcome of indwelling tunneled PleurX catheter placement in pediatric and young adult patients with malignant effusions . Pediatr Blood Cancer . 2014 ; 61 ( 6 ): 1118 ‐ 1120 .
den Hollander BS , Connolly BL , Sung L , et？al. Successful use of indwelling tunneled catheters for the management of effusions in children with advanced cancer . Pediatr Blood Cancer . 2014 ; 61 ( 6 ): 1007 ‐ 1012 .
Freites‐Martinez A , Santana N , Arias‐Santiago S , Viera A . Using the Common Terminology Criteria for Adverse Events (CTCAE ‐ Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies . Actas Dermosifiliogr (Engl Ed) . 2021 Jan; 112 ( 1 ): 90 ‐ 92 . https://doi.org/10.1016/j.ad.2019.05.009
Kriegel I , Daniel C , Falcou M‐C , et？al. Use of a subcutaneous implantable pleural port in the management of recurrent malignant pleurisy: five‐year experience based on 168 subcutaneous implantable pleural ports . J Palliat Med . 2011 ; 14 ( 7 ): 829 ‐ 834 .
Thomas JM , Musani AI . Malignant pleural effusions . Clin Chest Med . 2013 ; 34 ( 3 ): 459 ‐ 471 .
Roberts ME , Neville E , Berrisford RG , Antunes G , Ali NJ , BTS Pleural Disease Guideline Group . Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 . Thorax . 2010 ; 65 (Suppl 2 ): ii32 ‐ ii40 .
Feller‐Kopman DJ , Reddy CB , DeCamp MM , et？al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline . Am J Respir Crit Care Med . 2018 ; 198 ( 7 ): 839 ‐ 849 .
Reddy CB , DeCamp MM , Diekemper RL , et？al. Summary for clinicians: clinical practice guideline for management of malignant pleural effusions . Ann Am Thorac Soc . 2019 ; 16 ( 1 ): 17 ‐ 21 .
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.